Table 4.
Cox regression of all-cause death in the overall MAFLD patients grouped by PA level.
| Variables | PA inactive | PA active | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| HEI score | 0.992 (0.986–0.997) | 0.002 | 0.999 (0.994–1.004) | 0.672 |
| PA level | 0.993 (0.986–1.000) | 0.043 | 1.000 (0.999–1.001) | 0.948 |
| Male, n (%) | 1.220 (1.022–1.455) | 0.027 | 1.125 (0.937–1.352) | 0.207 |
| Age (years) | 1.063 (1.053–1.073) | <0.001 | 1.070 (1.060–1.080) | <0.001 |
| Race, n (%) | 1.160 (0.974–1.382) | 0.097 | 1.261 (1.041–1.527) | 0.018 |
| Low educational level | 1.170 (0.999–1.370) | 0.051 | 1.012 (0.863–1.188) | 0.880 |
| Low family income | 1.017 (0.861–1.201) | 0.848 | 1.264 (1.026–1.558) | 0.028 |
| Overdrink, n (%) | 1.426 (1.065–1.910) | 0.017 | 1.253 (0.918–1.709) | 0.155 |
| Type 2 diabetes, n (%) | 1.222 (1.013–1.475) | 0.036 | 1.069 (0.881–1.297) | 0.501 |
| Hypertension, n (%) | 1.245 (1.049–1.479) | 0.012 | 1.200 (1.012–1.423) | 0.036 |
| BMI (kg/m2) | 1.003 (0.988–1.019) | 0.685 | 0.986 (0.968–1.004) | 0.123 |
| WHR | 5.234 (1.989–13.770) | 0.001 | 3.582 (1.132–11.328) | 0.030 |
| HbA1c (%) | 1.078 (1.027–1.132) | 0.003 | 1.145 (1.087–1.207) | 0.000 |
| Cholesterol (mmol/L) | 1.009 (0.943–1.081) | 0.788 | 0.995 (0.931–1.064) | 0.890 |
| Triglyceride (mmol/L) | 1.065 (1.016–1.117) | 0.009 | 1.018 (0.970–1.067) | 0.472 |
| AST (U/L) | 1.019 (1.009–1.029) | <0.001 | 1.007 (1.000–1.013) | 0.038 |
| ALT (U/L) | 0.984 (0.976–0.992) | <0.001 | 0.995 (0.988–1.001) | 0.107 |
| eGFR (ml/min/1.73m2) | 0.992 (0.987–0.997) | 0.003 | 0.996 (0.990–1.002) | 0.177 |
| FIB-4 scores | 0.985 (0.801–1.212) | 0.888 | 1.130 (0.991–1.288) | 0.067 |
| NFS scores | 1.021 (0.933–1.116) | 0.657 | 1.026 (0.938–1.122) | 0.582 |
MAFLD Metabolic (dysfunction-) associated fatty liver disease, HEI healthy Eating Index, BMI body mass index, WHR Waist hip ratio, HbA1c glycosylated hemoglobin, ALT alanine aminotransferase, AST aspartate aminotransferase, eGFR estimated glomerular filtration rate; FIB-4 fibrosis 4 index, NFS NAFLD fibrosis score.